Atopic Dermatitis

A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

A Clinical Study to Evaluate SM17 for Atopic Dermatitis

A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis

Phase 2 Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD

A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis

Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis

Seal, Stopping Eczema and Allergy Study

A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis

A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema

A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis

Phase 2 Trial of HY209gel in Atopic Dermatitis Patients

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

A Study Evaluating TRIV-509 in Atopic Dermatitis

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis

A Study of JNJ-95597528 in Participants With Moderate to Severe Atopic Dermatitis

A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

A Study of JNJ-95475939 in the Treatment of Participants With Moderate to Severe Atopic Dermatitis (AD)

A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis

Evaluate the Safety, Tolerability of BAT6026

A Study of Barzolvolimab in Patients With Atopic Dermatitis

A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis

Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome

ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis

A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis

Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)

Cardamom and Topical Roseomonas in Atopic Dermatitis

A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis

A Study to Assess the Efficacy of GX-03 in Moderate to Severe Eczema (Atopic Dermatitis)

A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis

A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis

A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic Dermatitis

A Study for HSK44459 in Participants With Atopic Dermatitis

Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot Study

Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis

A Study Evaluating APG777 in Atopic Dermatitis

Evaluation of 611 in Chinese Children and Adolescents With Moderate to Severe Atopic Dermatitis

A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.

Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)

A Phase 2 Study to Evaluate the Efficacy, Safety of SIM0278 in Subjects With Moderate to Severe Atopic Dermatitis

Study of Dupilumab to Demonstrate Efficacy in Subjects With Nummular Eczema

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

Study of CM512 in Patients With Moderate-to-Severe Atopic Dermatitis

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

A Study of MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis

Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.

A Study to Evaluate the Efficacy and Safety of IN-115314 Ointment in Mild to Moderate Atopic Dermatitis Adult Patients

A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis

Evaluate the Efficacy and Safety of XKH001 Injection in Patients With Moderate-to-Severe Atopic Dermatitis

LaCE (Lactobacillus Paracasei LPB27 On Early Childhood Eczema)

Efficacy of Topical Cannabidiol for Eczema

Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis

A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Subjects With Atopic Dermatitis

A Study to Assess Efficacy and Safety of CGB-500, 1% Tofacitinib Versus an Active Comparator for Atopic Dermatitis

A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis

A Study to Assess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of Lutikizumab

IB/IIa Study of MG-K10 in Adolescent Moderately Severe Patients

A Herbal Compound for Eczema

A Clinical Study of AK120 in Adolescents With Moderate-to-severe Atopic Dermatitis (AD)

A Study to Evaluate the Efficacy and Safety of AK120 in Subjects With Moderate to Severe Atopic Dermatitis

A Study of TAVO101 in Atopic Dermatitis Patients

Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis

Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)

Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

A Study of CM310 in Subjects With Moderate-to-Severe Atopic Dermatitis

An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis

A Trial to Evaluate the Efficacy and Safety of Different Doses of LEO 138559 in Adults With Moderate-to-severe Atopic Dermatitis

Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

A Study to Evaluate the Efficacy and Safety of LNK01004 Ointment in Adults With Atopic Dermatitis

To Assess the Efficacy and Safety of SCD-044 in the Treatment of Moderate to Severe Atopic Dermatitis

Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis

Tofacitinib for Immune Skin Conditions in Down Syndrome

Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis

Safety Study of Roflumilast Cream 0.05% in Infants Aged 3 Months to Less Than 2 Years With Atopic Dermatitis

Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis

A Study of LY3454738 in the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis

Allergic Disease Onset Prevention Study

Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.

A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis

A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD)

A Single-ascending Dose (Part A) and Repeat-dose (Part B) Study to Investigate the Safety, Pharmacokinetics and Efficacy (Part B Only) of UCB1381 in Healthy Study Participants (Part A) and in Study Participants With Moderate to Severe Atopic Dermatitis (Part B)

A Study in Patients With Atopic Eczema to Test How Effective BI 655130 is and How Well it is Tolerated

POC Study to Evaluate BSI-045B in Moderate-to-severe Atopic Dermatitis

Study of LW402 in Moderate-to-Severe Atopic Dermatitis

A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis

MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis

A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis

Phase 2a Study of the Safety, Tolerability, and Pharmacokinetics of Topically Administered PRN473 (SAR444727) in Patients With Mild to Moderate Atopic Dermatitis

Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis

Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis

Effect of Benralizumab in Atopic Dermatitis

A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis

Topical Ruxolitinib Evaluation in Chronic Hand Eczema

Skin bioMARkers for Atopic Eczema Therapy Evaluation

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis

Study Testing Response Effect of KY1005 Against Moderate-to-Severe Atopic Dermatitis, The STREAM-AD Study

A Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Treated With Nemolizumab

A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis

Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis

Study of ATI-2138 in Adult Participants With Moderate to Severe Atopic Dermatitis

Study of TDM-180935 in Atopic Dermatitis Patients

A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.

Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema

A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis

A Multi-omics Disease Signature Trial in Adult Patients With Moderate to Severe AD

Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)

Study to Assess the Efficacy and Safety of Orismilast in Atopic Dermatitis (ADESOS)

A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic Dermatitis

Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis

Phase 2 Study of Efficacy and Safety of AK120, in Subjects With Moderate-to-Severe Atopic Dermatitis

Proof of Concept, Twice Daily Applications of LEO 124249 Ointment in the Treatment of Chronic Hand Eczema

Safety and Efficacy of a Topical Scalp Treatment for Dry Scalp Conditions in Children and Adult

A Study to Test the Long-term Safety of BI 655130 in Patients With Atopic Eczema Who Took Part in Study 1368-0032

A Study to Learn How Well the Study Treatment Zabedosertib (BAY1834845) Works and How Safe it is Compared to Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis

This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).

Tolerability and Effectiveness of CGB-500 Topical Ointment, 1% Tofacitinib, for the Treatment of Atopic Dermatitis

A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis

B244 Topical Spray for the Treatment of Pruritus in Adults With a History of Atopic Dermatitis

A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic Dermatitis

Efficacy and Safety of Dupilumab Chronic Hands Eczema Refractory to Highly Potent Topical Corticosteroids

Open-label Pilot Clinical Trial of Oral Ivermectin to Treat Atopic Dermatitis

A Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic Dermatitis

A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis

The Study of CM310 in Patients With Atopic Dermatitis

A Clinical Trial in Subjects With Atopic Dermatitis (Part 1)

Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis

Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis

Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis

A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis

A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.

Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis Involvement

Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

Proof of Concept Study of Rilzabrutinib in Adult Patients With Moderate-to-severe Atopic Dermatitis

A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.

Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

Efficacy and Safety of LEO 152020 Tablets for the Treatment of Adults With Moderate to Severe Atopic Dermatitis

A Study to Evaluate the Efficacy and Safety of CBP-201 in Moderate to Severe Atopic Dermatitis in China

Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis

Phase 2b Study of ASLAN004 in Adults With Moderate-to-Severe Atopic Dermatitis

Apremilast 30 mg Twice Daily (BID) Combined With Dupilumab

A Clinical Trial of BMX-010 in Adult Subjects With Atopic Dermatitis

Safety and Efficacy of ARQ-252 Cream in Subjects With Chronic Hand Eczema

Jaktinib Hydrochloride Cream For Atopic Dermatitis

A Phase Ⅱ Study of Hemay808 for Atopic Dermatitis Patients

A Study of Hemay005 in Adult With Atopic Dermatitis

Evaluation of 611 in Chinese Adults With Moderate to Severe Atopic Dermatitis

Efficacy and Safety Study of SHR-1819 Injection in Adult Patients With Severe Atopic Dermatitis

A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Atopic Dermatitis

A Study for AR100DP1 in Mild to Moderate Atopic Dermatitis (AD)

Evaluation of Mepitel Film® in Preventing Epidermitis in Patients Receiving Radiation Therapy for Breast Cancer

Study the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel

The Purpose of the Study is to Evaluate the Effect of Ruxolitinib Cream on Itch in Participants With Atopic Dermatitis

A Study of LNK01001 Capsule in Patients With Moderate to Severe Atopic Dermatitis

A Study of BMS-986166 or Branebrutinib for the Treatment of Participants With Atopic Dermatitis

Efficacy and Safety of MEDI3506 in Adult Subjects With Atopic Dermatitis

Study of ATI-1777 in Adult Patients With Moderate or Severe Atopic Dermatitis

Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials

Efficacy and Safety Study of the Use of Benralizumab for Patients With Moderate to Severe Atopic Dermatitis

A Study Investigating the Effect of EDP1815 in the Treatment of Mild, Moderate and Severe Atopic Dermatitis

Immunomodulation by OM-85 (Broncho-Vaxom) in Early AD

A Study to Assess the Efficacy and Safety of CBP-201 in Adult Subjects With Moderate to Severe Atopic Dermatitis

Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)

A First-in-Human PoC Study With BEN2293 in Patients With Mild to Moderate Atopic Dermatitis

Safety and Efficacy of SCM-AGH in Subjects With Moderate to Severe Atopic Dermatitis

Efficacy, Safety, and Pharmacokinetic Profile of Etokimab (ANB020) in Adult Participants With Moderate-to-Severe Atopic Dermatitis

A Study of Bermekimab for the Treatment of Adult Participants With Moderate-to-Severe Atopic Dermatitis

A Phase II Study in Adult Patients With Moderate to Severe Atopic Dermatitis

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis

Safety and Efficacy of CD5024 0.3% Cream in Subjects With Atopic Dermatitis

A Pharmacokinetics and Safety Study of Nemolizumab in Adolescent Participants With Atopic Dermatitis (AD)

Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function

Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone

Clinical Study of Jaktinib in the Treatment of Patients With Moderate and Severe Atopic Dermatitis

PRAgmatic Trial in Atopic Dermatitis Testing Long-term Control Effectiveness of New Phototherapy Regimen During Winter Coupled With Oral Vitamin D Supplementation vs. Placebo

A Study of Bermekimab (JNJ-77474462) in the Treatment of Participants With Moderate to Severe Atopic Dermatitis

Safety and Efficacy of ARQ-151 Cream in Adolescents and Adults With Atopic Dermatitis

Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis

Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis

A Study of KY1005 in Patients With Moderate to Severe Atopic Dermatitis

Evaluation of 611 in Chinese Adult Patients With Moderate-to-Severe Atopic Dermatitis

Efficacy and Safety of Orally Administered DS107 in Adult Patients With Moderate to Severe Atopic Dermatitis

Safety and Efficacy Study of Topically Applied DS107 Cream in Mild to Moderate Atopic Dermatitis Patients (AD)

A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis

Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis

A Multiple-Dose Study of BLU-5937 in Chronic Pruritus Associated With Atopic Dermatitis

Efficacy and Safety Study of Orally Administered DS107 in Moderate to Severe Atopic Dermatitis Patients

Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis

Oral DS107 in Moderate to Severe Atopic Dermatitis

Safety, Pharmacokinetics and Efficacy of FMX114 Versus Vehicle in Adults With Atopic Dermatitis

Study To Assess Efficacy, Safety, Tolerability And Pharmacokinetics Of PF-07038124 Ointment In Participants With Atopic Dermatitis Or Plaque Psoriasis

Phase 2b Study to Evaluate the Efficacy and Safety of ISB 830 in Adults With Moderate to Severe Atopic Dermatitis

Study of TER-101 Topical Ointment in Subjects With Atopic Dermatitis

Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

Subcutaneously CM310/Placebo in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis

Medihoney® Derma Cream Treatment for Mild to Moderate Atopic Dermatitis in Children Study

A Dose Ranging Placebo-Controlled Double-Blind Study to Evaluate the Safety and Efficacy of Tezepelumab in Atopic Dermatitis

A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon)

A NOVel Moisturiser for Atopic Dermatitis: Effect on the Skin Barrier

Efficacy and Safety of REGN3500 Monotherapy and Combination of REGN3500 Plus Dupilumab in Adult Patients With Moderate-to-Severe Atopic Dermatitis

Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study

An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema

A Study to Assess the Safety and Efficacy of ZPL389 in Patients With Moderate to Severe Atopic Dermatitis

A Study to Assess the Safety and Efficacy of ZPL389 With TCS/TCI in Atopic Dermatitis Patients

Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis

Thykamine Safety and Efficacy Study in Mild-to-Moderate Atopic Dermatitis

Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis

Clobetasol Topical Oil for Children With Moderate to Severe Atopic Dermatitis

Observer-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. Placebo

A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis

Dose Escalation Trial of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis (AD)

Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis

A Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis

Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis

Study to Evaluate Safety & Efficacy of Topical ATx201 OINTMENT in Adolescents and Adults With Mild to Moderate AD

An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis

A Study of LY3375880 in Adults With Moderate-to-Severe Atopic Dermatitis

Treatment of Chronic Itch in Atopic Dermatitis With Topical Naltrexone

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Phosphate Cream Applied Topically to Adults With Atopic Dermatitis

Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis

A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis

Moisturizer to Prevent Atopic Dermatitis

A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticosteroids, in Adult Participants With Moderate to Severe Atopic Dermatitis

A Study to Determine the Safety and Tolerability of Dupilumab (REGN668/SAR231893) in Patients Aged ≥6 to <18 Years With Atopic Dermatitis (Eczema)

Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients

Clinical Evaluation of Metal Panel Allergens: Dose Response Study

Targeted Microbiome Transplant in Atopic Dermatitis

Study of OPA-15406 Ointment in Patients With Atopic Dermatitis

Phase 2 Study of OPA-15406 Ointment in Pediatric Patients With Atopic Dermatitis

A Study to Evaluate ABT-494 (Upadacitinib) in Adults With Moderate to Severe Atopic Dermatitis

Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis

A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis

To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis

Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients

Topical NanoDox® for Atopic Dermatitis

A Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis

Efficacy and Safety Study of Mepolizumab in Subjects With Moderate to Severe Atopic Dermatitis

A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis

A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis

Beginning Assessment of Cutaneous Treatment Efficacy of Roseomonas in Atopic Dermatitis

Dose-ranging Study of Nemolizumab in Atopic Dermatitis

A Phase II, Placebo-controlled Trial Evaluating the Efficacy of Antroquinonol in Patients With Atopic Dermatitis

Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Atopic Dermatitis

A Trial of Antroquinonol in Patients With Atopic Dermatitis

Crisaborole Ointment 2% Skin Biomarker Biopsy Study in Atopic Dermatitis

Secukinumab for Treatment of Atopic Dermatitis

A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis

An Ascending Multiple Dose Study of VTP-38543 in Adult Participants With Mild to Moderate Atopic Dermatitis

Efficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic Dermatitis

Study to Evaluate the Efficacy and Safety of ZL-3101 in Subjects With Subacute Eczema

A Trial of a Botanical Drug Product Containing East Indian Sandalwood Oil (EISO) For Treatment of Atopic Dermatitis

An Open Label, Safety Study to Assess the Potential for Adrenal Suppression.

Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis

Pharmacokinetics and Safety of MM36 Topical Ointment in Pediatric Subjects With Atopic Dermatitis

A Study to Evaluate the Efficacy and Safety of HAT01H in Atopic Dermatitis

A Study in Subjects With Moderate Atopic Dermatitis

Efficacy and Steroid Sparing Potential Study of DGLA Cream in Patients With Moderate to Severe Atopic Dermatitis

Study of RVT-501 in Adult and Adolescent Subjects With Atopic Dermatitis

Study of RVT-501 Topical Ointment in Pediatric Patients With Atopic Dermatitis

Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis

A Study of the Efficacy and Safety of Orvepitant in Subjects With Pruritus Associated With Atopic Dermatitis

DMT210 Topical Gel in the Treatment of Atopic Dermatitis

Topical Solution for the Treatment of Atopic Dermatitis

A Study to Evaluate the Safety and Efficacy of ATx201 in Subjects With Moderate Atopic Dermatitis

Phase 2a Study to Evaluate the Efficacy and Safety of MEDI9929 in Adults With Atopic Dermatitis

Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis

Safety, Pharmacokinetics and Preliminary Efficacy of Asimadoline in Pruritus Associated With Atopic Dermatitis

A Dose-Finding Study of GSK2894512 Cream in Subjects With Atopic Dermatitis (AD)

A Study of Lebrikizumab in Participants With Persistent Moderate to Severe Atopic Dermatitis

Efficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis Patients

Trial to Determine the Therapeutic Benefit of an OTC Cream on Dry, Itchy Skin of Adults and Children With Eczema

Efficacy and Tolerability of HAT1 in Patients With Moderate to Severe Atopic Dermatitis

Indigo Naturalis in Treating Atopic Dermatitis Topically

Safety and Efficacy Study of Q301 in Moderate to Severe Atopic Dermatitis Patients

A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Adults With Atopic Dermatitis

Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis

An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis

Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

Phase 1a/1b Study of TRB-061 in Healthy Participants & Atopic Dermatitis Patients

A Phase 1 Study of GS101 Injection

Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD

The Impact of Botox on Neuroimmune Interactions in Atopic Dermatitis

A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis

Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis

Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis

A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis

A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants

Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-7624 in Healthy Adult Participants

A Study on the Bioavailability of SHR-1819 Injection Administered Subcutaneously Using Different Injection Devices in Healthy Subjects

Safety, Tolerability and PK of ATTO-1310 in Healthy Volunteers and Patients With Atopic Dermatitis and Patients With Chronic Pruritus

Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis

A Phase I Clinical Trial to Evaluate CU-10101 Unguent

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)

A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis

A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis

A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients

A Study of Two Different Formulations of 611 in Healthy Adult Subjects in China

A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers

Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)

Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)

A Study to Evaluate Bioavailability of Rocatinlimab Autoinjector and Vial in Healthy Participants

A Study to Evaluate Rocatinlimab (AMG 451) in Healthy Chinese Participants

A Study to Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants

A Study of Orally Administered IPG7236 in Healthy Adult Participants

An Evaluation of 9MW1911 Injection in Healthy Subjects

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis

Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis

A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults

A Study of LY3872386 in Healthy Participants and Participants With Atopic Dermatitis

Study of CM512 in Healthy Subjects and Patients With Atopic Dermatitis

Safety and Tolerability of BSI-045B in Healthy Adult Subjects and Patients With Atopic Dermatitis

A First In Human (FIH) Study of IBI356 in Healthy Participants and in Atopic Dermatitis Patients

Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis

Topical ENS-002 for Atopic Dermatitis in Adults

Efficacy of Jelly Fig (Ficus Awkeotsang Makino) Extract for Atopic Dermatitis

A Phase I Clinical Study to Evaluate SM17 in Chinese Healthy Subjects and Patients With Moderate to Severe Atopic Dermatitis

The Mass Balance and Biotransformation Study of [14C] VC005 in Chinese Healthy Adult Male Volunteers

Eucrisa for Atopic Dermatitis

Multiple Rising Dose Study of MK-6194 in Participants With Atopic Dermatitis (MK-6194-008)

Pharmacokinetics of Delgocitinib 20 mg/g Cream in Subjects With Chronic Hand Eczema

A PhaseⅠ Comparative Study to Evaluate the Pharmacokinetics of QL2108 to Dupixent®

A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects

Drug-drug Interaction Trial With Tralokinumab in Moderate to Severe Atopic Dermatitis - ECZTRA 4

A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)

Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children

Safety and Tolerability of LEO 138559 in Healthy Subjects and Subjects With Atopic Dermatitis

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis

Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis

Targeted Investigation of Microbiome Elimination

A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis.

Safety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis.

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age Inclusive

A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis

A Study of B244 Delivered as a Topical Spray to Assess Safety in Pediatric Subjects With Atopic Dermatitis

Study to Evaluate Safety and Tolerability of PF-07242813 in Healthy Participants and Participants With Atopic Dermatitis

A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis

Evaluation of TLL-018 Extended and Immediate Release Formulation for Bioequivalence Testing in Healthy Chinese Subjects

A Study of LY3471851 in Participants With Eczema

A Safety, Tolerability and Pharmacokinetics Study of Topical Ointment YR001 in Adult Healthy Volunteers

A Clinical Study in Healthy Subjects to Evaluate 9MW1911 Injection

A First-In-Human Study to Evaluate the Safety, Tolerability, and Efficacy of Si-544 in Adults With Atopic Dermatitis

Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects

Study of Ruxolitinib Cream in Children With Atopic Dermatitis

A Safety, Tolerability and Preliminary Efficacy Study of FRTX-02 Capsules in Healthy Subjects and Subjects With Atopic Dermatitis

Pharmacokinetics (PK), Safety, Efficacy and Maximal Use PK of ARQ-151 in Adolescents/Children With Mild/Moderate Eczema

A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis

Study to Evaluate ASN008 Topical Gel (TG)

Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%

A Pharmacokinetic Study to Evaluate BBI-5000 Capsules and Food Effect in Healthy Adult Subjects

A Single-center, Randomized, Double-blinded, Placebo-controlled, Phase 1 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of NCP112

Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis

A First-in-Human Study of CEE321 in Adult Subjects

A Single and Multiple Ascending Dose Trial of KT-474 in Healthy Adult Volunteers and Patients With Atopic Dermatitis (AD) or Hidradenitis Suppurativa (HS)

Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma

A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis

A Non-Drug Study Detecting And Quantifying Nocturnal Scratch Behaviors From Wrist Actigraphy Data In Adult Healthy Volunteers And Participants With Atopic Dermatitis (AD)

A Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneously Delivered ASLAN004 in Adults With Moderate-Severe Atopic Dermatitis

A Study of EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

A Study of EDP1066 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

A Study of LY3454738 in Healthy Participants and Participants With Atopic Dermatitis

A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis

A Study of Single and Multiple Ascending Doses of KBL697 in Healthy Subjects

Effect of Different Skin Creams on TEWL

Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis

A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis

A Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic Dermatitis

Examination of Whether Host Preconditioning Modifies Short-term Transplant Survival

Validation of the Short-term Antimicrobial Action of Transplanted Bacteria

A Study to Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Called MOR106, in Healthy Subjects and in Patients With Moderate to Severe Atopic Dermatitis

A Maximum Use Trial of Ruxolitinib Cream in Adolescent and Adult Participants With Atopic Dermatitis

Study of KHK 4323 in Healthy Volunteers and Subjects With Atopic Dermatitis

Study of Commercial and Phase 3 of PF-04965842 Formulations, Estimation of Effect of Food on Commercial Formulation

Probiotic Supplementation in Breastfed Newborn Infants

Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients

A Study of Crisaborole Ointment 2% in Adult Japanese Healthy Subjects and Adult Japanese Subjects With Mild To Moderate Atopic Dermatitis

Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842.

A Phase 1b Study Assessing the PK, PD, Safety & Tolerability of SB414 in Atopic Dermatitis

Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis

A Phase 1 Study of KHK4083 in Subjects With Atopic Dermatitis

Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis

First in Human of Single and Multiple Doses of MOR106

Skin Irritation Study of GSK2894512 Cream

Pharmacokinetic Study of Topical GSK2894512 Cream

A Single Dose Phase I Exploratory Study in Healthy Volunteers With GSK2894512 Cream

An Explorative Trial Evaluating the Effect of LEO 32731 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects

Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)

A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin

The Impact of Dietary Salt on the Severity of Eczema

Bodewell Products for the Treatment of Atopic Dermatitis

Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis

Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic Eczema

Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients

A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

Comparative Study of Crisaborole vs. Tacrolimus in Atopic Dermatitis

Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

Dupilumab De-escalation in Pediatric Atopic Dermatitis

Ethnic Differences in Mechanisms of Action of Dupilumab

DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema

Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis

Lebrikizumab in Moderate-to-severe Atopic Dermatitis

Tralokinumab for Dupilumab Failures

Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis

Molecular Signatures of Cutaneous Dupilumab Response

Efficacy and Safety of Dupilumab in Combination With Tofacitinib in Moderate to Severe Adult AD Patients

Non-specific Effects of a Modified Measles Vaccination Schedule to Prevent Allergy and Unrelated Infection in Children

Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models

Dupixent and Narrowband UVB for Atopic Dermatitis

Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO)

Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis

Dupilumab in Adolescent and Adult Skin of Color Participants: Open-label Moderate-to-severe Eczema Trial

The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance.

Study of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With Dupilumab

Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis

Dupilumab Skin Barrier Function Study in Atopic Dermatitis

SAR231893-LPS15497- "Dupilumab Effect on Sleep in AD Patients"

Dupilumab Skin BArrier Function and LIpidomics STudy in Atopic Dermatitis in China

A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis

Effects of Abrocitinib in Subjects With Atopic Dermatitis With an Unsatisfactory Response After Treatment With Dupilumab

Short-Term Efficacy of Triamcinolone Acetonide (Aristocort® C) in Subjects with Atopic Dermatitis

Improvement In Scratch Behavior And Sleep In Patients With Atopic Dermatitis

Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? the D-Vex Pilot Study

Dupilumab-pediatric Skin Barrier Function and Lipidomics Study in Patients With Atopic Dermatitis in China

Investigation of Flare and Remission in Subjects With Atopic Dermatitis

Steroid-reducing Effects of Crisaborole

The Impact of Dupilumab on Quality of Life in Moderate to Severe Atopic Dermatitis Patients

Comparative Study:Topison (Mometasone Furoate) Versus Two Others Mometasone Furoates

The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment

Response of Children With Atopic Dermatitis (Eczema) to Eucrisa

A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers

A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD

Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis

Different Application Rates of Crisaborole Ointment 2% in Adults With Mild to Moderate Atopic Dermatitis

Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life

The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover

Pain Outcomes Following Intralesional Corticosteroid Injections

Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children

Effect of Sublingual Immunotherapy in Patients With Atopic Dermatitis

Evaluating Treatment Resistant Dermatitis TaroIIR

A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children?

Topical Steroid Formulation and Wet Wraps

A Study to Determine the Safety and Sensitizing Potential of HAT1 Topical Products Using Skin Sensitivity Patch Tests

Microbial Colonization and Change of Chronic Keratinized Hand Eczema After Using Halometasone Triclosan

Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis